OR WAIT null SECS
© 2022 MJH Life Sciences and BioPharm International. All rights reserved.
© 2022 MJH Life Sciences™ and BioPharm International. All rights reserved.
March 03, 2022
Thermo Fisher and Symphogen have extended their collaboration involving improved data workflow, which supports the discovery and development of new cancer treatments.
December 15, 2021
GlaxoSmithKline, together with the University of Oxford, has launched the Oxford-GSK Institute under a new collaboration that aims to study complex diseases to accelerate the success of drug discovery and drug development efforts.
April 01, 2020
Biopharma companies responding to the COVID-19 outbreak think accelerating the development of vaccines is safe.
March 27, 2020
The strategic alliance provides an integrated product offering around drug discovery and development.
August 01, 2019
Experts explore the role gene-editing techniques can play in regenerative medicine and cell-line development.
June 13, 2019
In this collaboration, AbCellera will apply its expertise to generate panels of antibody candidates for Gilead to evaluate.
May 28, 2019
Researchers at the University of Sheffield, Sheffield, UK, have discovered and developed a new compound that can kill antibiotic-resistant bacteria, including Escherichia coli.
May 01, 2019
The companies will join forces to use artificial intelligence (AI) and machine learning to discover and develop new treatments for two chronic diseases.
February 22, 2019
Valitacell and Solentim, have announced a collaboration aimed at the acceleration of discovery and development of biologic drugs and advanced cell therapies.
January 11, 2019
Researchers at the University of Delaware have made a step forward in gene therapy by engineering microparticles that deliver gene-regulating material to hematopoietic stem and progenitor cells, which live deep in bone marrow and direct the formation of blood cells.